GeneCentric will present two posters, including data on PurIST for pancreatic ductal adenocarcinoma and our new diagnostic program for colorectal cancer, at the AACR Annual Meeting to be held April 5-10, 2024 in San Diego, CA.

1040 / 20 – Development of a novel RNA-based microsatellite stable predictive response signature (MSS-PRS) to identify MSS colorectal cancer (CRC) patients with a microsatellite instability-high (MSI-H) molecular phenotype
Session PO.CL01.01 – Diagnostic Biomarkers 1
Section 42
Date: April 7, 2024
Time: 1:30pm – 5:00pm

2542 / 2 – Real-world validation of the PurIST classifier demonstrates enhanced therapy selection for pancreatic ductal adenocarcinoma (PDAC) patients
Session PO.CL10.01 – Real-World Biomarkers
Section 45
Date: April 8, 2024
Time: 9:00am – 12:30pm

In addition, please reach out ([email protected]) if you would like to schedule a 1:1 meeting with our team. Learn more about AACR 2024 and register here: https://www.aacr.org/meeting/aacr-annual-meeting-2024/